{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:28:26Z","timestamp":1793125706346,"version":"4.5.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Social and People\u2019s Livelihood Project of Nantong","award":["MS22022001"],"award-info":[{"award-number":["MS22022001"]}]},{"name":"Clinical Research Program of Nantong University","award":["2022LZ005"],"award-info":[{"award-number":["2022LZ005"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-024-01549-9","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T03:44:03Z","timestamp":1734579843000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of frequency changes in CD8+ regulatory T cell subsets in peripheral blood of individuals with type 1 diabetes"],"prefix":"10.1186","volume":"16","author":[{"given":"Shu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoqiang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"1549_CR1","doi-asserted-by":"publisher","first-page":"999108","DOI":"10.3389\/fimmu.2022.999108","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Xiao Y, Xie L, et al. Lipid metabolism in type 1 diabetes mellitus: Pathogenetic and therapeutic implications. Front Immunol. 2022;13:999108. https:\/\/doi.org\/10.3389\/fimmu.2022.999108.","journal-title":"Front Immunol"},{"key":"1549_CR2","doi-asserted-by":"publisher","first-page":"j5295","DOI":"10.1136\/bmj.j5295","volume":"360","author":"J Weng","year":"2018","unstructured":"Weng J, Zhou Z, Jia W, T1D China Study Group, et al. Incidence of type 1 diabetes in China, 2010-13: population based study. BMJ. 2018;360:j5295. https:\/\/doi.org\/10.1136\/bmj.j5295.","journal-title":"BMJ"},{"key":"1549_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41422-020-0324-7","volume":"30","author":"N Ohkura","year":"2020","unstructured":"Ohkura N, Sakaguchi S. Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases. Cell Res. 2020;30:465\u201374. https:\/\/doi.org\/10.1038\/s41422-020-0324-7.","journal-title":"Cell Res"},{"key":"1549_CR4","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1158\/2326-6066.CIR-16-0193","volume":"4","author":"G Plitas","year":"2016","unstructured":"Plitas G, Rudensky AY. Regulatory T cells: differentiation and function. Cancer Immunol Res. 2016;4:721\u20135. https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0193.","journal-title":"Cancer Immunol Res"},{"key":"1549_CR5","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1172\/JCI28801","volume":"117","author":"C Guillonneau","year":"2007","unstructured":"Guillonneau C, Hill M, Li XL, et al. CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-\u03b3, and indoleamine 2,3-dioxygenase. J Clin Invest. 2007;117:1096\u2013106. https:\/\/doi.org\/10.1172\/JCI28801.","journal-title":"J Clin Invest"},{"issue":"2","key":"1549_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4049\/jimmunol.2100558","volume":"209","author":"JR Dwyer","year":"2022","unstructured":"Dwyer JR, Racine JJ, Chapman HD, Quinlan A, Presa M, Stafford GA, Schmitz I, Serreze DV. Nfkbid overexpression in nonobese diabetic mice elicits complete type 1 diabetes resistance in part associated with enhanced thymic deletion of pathogenic CD8 T cells and increased numbers and activity of regulatory T cells. J Immunol. 2022;209(2):227\u201337. https:\/\/doi.org\/10.4049\/jimmunol.2100558.","journal-title":"J Immunol"},{"key":"1549_CR7","doi-asserted-by":"publisher","first-page":"708874","DOI":"10.3389\/fimmu.2021.708874","volume":"12","author":"S Mishra","year":"2021","unstructured":"Mishra S, Srinivasan S, Ma C, Zhang N. CD8\u2009+\u2009Regulatory T cell - A mystery to be revealed. Front Immunol. 2021;12:708874. https:\/\/doi.org\/10.3389\/fimmu.2021.708874.","journal-title":"Front Immunol"},{"key":"1549_CR8","doi-asserted-by":"publisher","first-page":"3694957","DOI":"10.1155\/2016\/3694957","volume":"2016","author":"YC Qiao","year":"2016","unstructured":"Qiao YC, Shen J, Zhao HL, et al. Changes of regulatory T cells and of proinflammatory and Immunosuppressive cytokines in patients with type 2 diabetes mellitus: a systematic review and Meta-analysis. J Diabetes Res. 2016;2016:3694957. https:\/\/doi.org\/10.1155\/2016\/3694957.","journal-title":"J Diabetes Res"},{"key":"1549_CR9","doi-asserted-by":"publisher","first-page":"1278759","DOI":"10.3389\/fimmu.2023.1278759","volume":"14","author":"R Kennedy-Batalla","year":"2024","unstructured":"Kennedy-Batalla R, Acevedo D, Alsina L, et al. Treg in inborn errors of immunity: gaps, knowns and future perspectives. Front Immunol. 2024;14:1278759. https:\/\/doi.org\/10.3389\/fimmu.2023.1278759.","journal-title":"Front Immunol"},{"key":"1549_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fimmu.2015.00171","volume":"6","author":"G Churlaud","year":"2015","unstructured":"Churlaud G, Pitoiset F, Klatzmann D, et al. Human and mouse CD8(+)CD25(+)FOXP3(+) regulatory T cells at steady state and during interleukin-2 therapy. Front Immunol. 2015;6:171. https:\/\/doi.org\/10.3389\/fimmu.2015.00171.","journal-title":"Front Immunol"},{"issue":"7","key":"1549_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.humimm.2019.03.014","volume":"80","author":"AM Zahran","year":"2019","unstructured":"Zahran AM, Nafady-Hego H, Hetta HF, et al. Increased frequency and FOXP3 expression of human CD8+CD25High+ T lymphocytes and its relation to CD4 regulatory T cells in patients with hepatocellular carcinoma. Hum Immunol. 2019;80(7):510\u20136.","journal-title":"Hum Immunol"},{"issue":"6","key":"1549_CR12","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41423-018-0058-3","volume":"16","author":"M Zhang","year":"2019","unstructured":"Zhang M, Wang S, Wang L, et al. An altered CD8+ T cell epitope of insulin prevents type 1 diabetes in humanized NOD mice. Cell Mol Immunol. 2019;16(6):590\u2013601. https:\/\/doi.org\/10.1038\/s41423-018-0058-3.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"1549_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.immuni.2010.03.015","volume":"32","author":"S Tsai","year":"2010","unstructured":"Tsai S, Shameli A, Santamaria P, et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity. 2010;32(4):568\u201380. https:\/\/doi.org\/10.1016\/j.immuni.2010.03.015.","journal-title":"Immunity"},{"issue":"12","key":"1549_CR14","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1182\/blood-2003-04-1320","volume":"102","author":"L Cosmi","year":"2003","unstructured":"Cosmi L, Liotta F, Annunziato F, et al. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood. 2003;102(12):4107\u201314. https:\/\/doi.org\/10.1182\/blood-2003-04-1320.","journal-title":"Blood"},{"issue":"5","key":"1549_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Ono M, et al. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775\u201387. https:\/\/doi.org\/10.1016\/j.cell.2008.05.009.","journal-title":"Cell"},{"issue":"6","key":"1549_CR16","doi-asserted-by":"publisher","first-page":"e24521","DOI":"10.4161\/onci.24521","volume":"2","author":"T Grimmig","year":"2013","unstructured":"Grimmig T, Kim M, Waaga-Gasser AM, et al. The role of FOXP3 in disease progression in colorectal cancer patients. Oncoimmunology. 2013;2(6):e24521. https:\/\/doi.org\/10.4161\/onci.24521.","journal-title":"Oncoimmunology"},{"issue":"4","key":"1549_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1182\/blood-2017-09-807156","volume":"132","author":"K Agle","year":"2018","unstructured":"Agle K, Vincent BG, Drobyski WR, et al. Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. Blood. 2018;132(4):435\u201347. https:\/\/doi.org\/10.1182\/blood-2017-09-807156.","journal-title":"Blood"},{"issue":"1","key":"1549_CR18","doi-asserted-by":"publisher","first-page":"e000873","DOI":"10.1136\/bmjdrc-2019-000873","volume":"8","author":"M Gliwi\u0144ski","year":"2020","unstructured":"Gliwi\u0144ski M, Iwaszkiewicz-Grze\u015b D, Trzonkowski P, et al. Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy. BMJ Open Diabetes Res Care. 2020;8(1):e000873. https:\/\/doi.org\/10.1136\/bmjdrc-2019-000873.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"5","key":"1549_CR19","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.immuni.2008.03.016","volume":"28","author":"Q Tang","year":"2008","unstructured":"Tang Q, Adams JY, Bluestone JA, et al. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 2008;28(5):687\u201397. https:\/\/doi.org\/10.1016\/j.immuni.2008.03.016.","journal-title":"Immunity"},{"issue":"9","key":"1549_CR20","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1084\/jem.20100209","volume":"207","author":"Y Grinberg-Bleyer","year":"2010","unstructured":"Grinberg-Bleyer Y, Baeyens A, Piaggio E, et al. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J Exp Med. 2010;207(9):1871\u20138. https:\/\/doi.org\/10.1084\/jem.20100209.","journal-title":"J Exp Med"},{"issue":"1","key":"1549_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/ijms23010390","volume":"23","author":"I Ben-Skowronek","year":"2021","unstructured":"Ben-Skowronek I, Sieniawska J, Rosolowska I, et al. Potential therapeutic application of regulatory T cells in diabetes mellitus type 1. Int J Mol Sci. 2021;23(1):390. https:\/\/doi.org\/10.3390\/ijms23010390.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1549_CR22","doi-asserted-by":"publisher","first-page":"e0210839","DOI":"10.1371\/journal.pone.0210839","volume":"14","author":"M Pellegrino","year":"2019","unstructured":"Pellegrino M, Crin\u00f2 A, Fierabracci A, et al. Identification and functional characterization of CD8\u2009+\u2009T regulatory cells in type 1 diabetes patients. PLoS ONE. 2019;14(1):e0210839. https:\/\/doi.org\/10.1371\/journal.pone.0210839.","journal-title":"PLoS ONE"}],"container-title":["Diabetology & Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-024-01549-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-024-01549-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:15:41Z","timestamp":1734585341000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-024-01549-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1549"],"URL":"https:\/\/doi.org\/10.1186\/s13098-024-01549-9","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,19]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki(as was revised in 2013). The study was approved by Ethics Committee of the Nantong First People\u2019s Hospital (2024KT358). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}